Genome Sequencing Market | Size, Share, Growth, Analysis

THE GLOBAL GENOME SEQUENCING MARKET SIZE WAS VALUED AT USD 2.9 BILLION IN 2020 AND IS EXPECTED TO REACH 5 BILLION BY 2026, GROWING AT A CAGR OF 9% DURING THE FORECAST PERIOD

Genome Sequencing Market Size, Share, Trends Analysis Report by

Products (Consumables and Sequencers & Software)
Application (Oncology, Reproductive Health, Complex Disease Research, Microbial Research, and Others)
End-user (Academic & Research Institutes, Pharma & Biotech Companies, Consumer Genomic Service Providers, Government & Commercial Laboratories, and Others)
Geography (North America, Europe, APAC, Latin America, and Middle East & Africa)

Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2021–2026

Customize this Report

This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize

GLOBAL GENOME SEQUENCING MARKET REPORT SCOPE

REPORT ATTRIBUTE	DETAILS
MARKET SIZE (REVENUE)	5 BILLION (2026)
CAGR	9% (2021–2026)
Largest Share by Product Type	CONSUMABLES
Largest Share by Application Type	ONCOLOGY
Largest Share by End-User Type	ACADEMIC & RESEARCH INSTITUTE
Largest Market by Region	NORTH AMERICA
Countries Covered	US, Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, Australia, India, Brazil, Mexico, Argentina, Saudi Arabia, Turkey, South Africa, and UAE

Interested in this Report?

Download a Sample!

INDUSTRY INSIGHTS

The global genome sequencing market size was valued at USD 2.9 billion in 2020 and is expected to reach USD 5 billion by 2026, growing at a CAGR of 9% during 2021-2026.

The constant increase in cancer cases is proportionately increasing the number of sequencing-based diagnostics and treatment options in the market. With pharma and biotechnological companies displaying a keen interest in genome sequencing, vendors provide an innovative portfolio of next-generation sequencing(NGS) systems, products, and services. Drug companies have launched medicines targeting DNA and RNA, which is expected to influence the global genome sequencing market significantly. Factors such as increasing awareness and strong interests from the individuals to know about their genomics are boosting the demand.

GLOBAL GENOME SEQUENCING MARKET: KEY HIGHLIGHTS

Consumables are expected to witness an incremental growth of over USD 2 billion by 2026.
The application of oncology genome sequencing is expected to grow at a CAGR of approx. 10% during 2020–2026.
The revenue contribution from academic and research institutes is likely to cross over USD 16 billion by 2026
Consumer genomic service providers are projected to grow at the highest CAGR of approx. 10% during 2020–2026
North America and Europe are likely to account for the largest genome sequencing market share during the forecast period

KEY OPPORTUNITIES IN THE NEXT GENERATION SEQUENCING MARKET

Increase in the demand for single-cell sequencing
Introduction Of Portable Devices
Emergence Of Nanopore, Third Generation Genome Sequencing Platform

Check out our latest report on : Artificial Intelligence in Genomics Market - Global Outlook & Forecast 2022-2027

MARKET SHARE & SEGMENTS

High innovations and the introduction of high throughput technologies are likely to drive the application of DNA sequencing devices.

The steady rise in the sale of high-end consumables in commercial laboratories, research institutes, academic institutes, and large pharma and biotech companies performing a high volume of sequencing-based processes is a significant factor responsible growth of consumables segment. In 2020, the consumables segment accounted for the largest share in the market, with 81%. The recurring application of consumables to perform a wide range of studies and diagnostics is another critical factor for high sales for consumables. Moreover, increased preference for array-based genotyping consumables for a wide range of analysis, disease-related mutations, and genetic characteristics associated with cancer research is further expected to increase the demand for consumables during the forecast period.

NGS changing the future of oncology

New cancer cases are expected to reach 24 million by 2030, which is likely to augur well for the growth of the oncology segment. As cancer prevalence is growing, the need for effective patient stratification is driving research efforts to identify biomarkers and develop companion diagnostics. DNA sequencing technology has opened new ways of studying cancer-related conditions. With targeted therapies becoming the new standard of care in oncology, NGS-driven diagnostics are widely observed as driving the selection of treatments to provide better outcomes to the patient population. Thus, augmenting the demand for NGS sequencers in cancer research centers. The promising outcome of clinical DNA sequencing to diagnose and treat rare genetic disorders is likely to bode well for the genome sequencing market growth.

Consumer and genomic service providers end-user segment to witness an incremental growth of USD 1 Billion by 2026

The global genome sequencing market by academic & research institutes is expected to grow at a CAGR of 9.5% during the forecast period. The presence of several research institutes and stand-alone genomic laboratories in the US, the UK, Germany, France, and China is a major factor responsible for the growth of the segment. To develop personalized and effective new therapies that restore mobility, enhance the quality of life, and improve surgical outcomes for patients with multiple disorders, these centers perform extensive research on sequence structural levels of genomics. Hence, the increased focus on unraveling genetic components of common and complex diseases, including cancer diagnostics, neurological disorders, infectious diseases, and rare childhood disorders, influences the global DNA sequencing market.

Genomic service providers are increasing drastically over time, especially in underdeveloped and developing countries, research institutes that are not able to afford the DNA sequencing laboratory infrastructure prefer the genomic service providers for their sample analysis. This trend has eventually increased the demand for service providers in the market. Several pharma companies are also collaborating with DNA sequencing service providers to obtain data for their product development. The reduction in the cost of the service has made companies to enter this space of genome sequencing servicing.

GEOGRAPHICAL INSIGHTS

North America and Europe are the largest genome sequencing market across the globe. They are the leading countries to increase the usage of genome based healthcare and diagnostics. The US is the largest revenue contributor to the North American market. The advanced healthcare infrastructure and the increased awareness have slowly increased genome sequencing and cell and gene therapies technology penetration. Multiple initiatives for human genome projects in the US have improved patients' flow seeking treatment for several terminal and genetic diseases. With advances in technology and the increased demand for personalized treatment, the US genomic sequencing market is poised for growth. The increased awareness among European patients drives the market of personal genome testing, especially for reproductive health. There is an increased number of consumer genomic service providers in the market.

COMPETITIVE LANDSCAPE

Illumina, Thermo Fisher Scientific, F. Hoffmann-La Roche, BGI, Pacific Biosciences, Oxford Nanopore Technology are the key market players. The market is competitive and is evolving with the introduction of new technologies the market. Several companies are developing or commercializing products, expanding their manufacturing facilities, partnering with others in the market. For instance, in 2020, Illumina introduced software for whole-genome analysis to examine rare diseases. Similarly, Thermo Fischer scientific has made a strategic partnership with First genetics JCS to promote NGS in Russia. The Oxford Nanopore technology, nanopore-based sequencing, and Pacbio’s SMRT technology-based method revolutionize the industry by reducing cost and increasing throughput, attracting end-users to shift from conventional sanger methods to advanced methods in the market.

The global genome sequencing market research report includes in-depth coverage of the industry analysis with revenue and forecast insights for the following segments:

Product

Consumables
Sequencers & Software

Application

Oncology
Reproductive Health
Complex Disease Research
Microbial Research
Others

End-user

Academic & Research Institutes
Pharma & Biotech Companies
Consumer Genomic Service Providers
Government & Commercial Laboratories
Others

Geography

North America

US
Canada

Europe

UK
Germany
France
Italy
Spain

Asia Pacific

China
India
Japan
South Korea
Australia

Latin America

Mexico
Brazil
Argentina

Middle East & Africa

Saudi Arabia
Turkey
South Africa
UAE

Frequently Asked Questions

How big is the global DNA/Genome Sequencing market size?

The global genome sequencing market size was valued at USD 2.9 billion in 2020 and is expected to reach USD 5 billion by 2026, growing at a CAGR of 9% during 2021-2026.

What technological advances are the genome sequencing market observing?

The introduction of portable gene sequencing devices and nanopore technology applications are major technological advances in the genome sequencing market.

What is the growth rate of the genome sequencing market during the forecast period?

The Global genome sequencing market is expected to grow at a CAGR of over 9% during 2021–2026.

How the outbreak of the COVID-19 pandemic affect the genome sequencing market?

The COVID-19 pandemic outbreak has increased pressure on clinical research and genomic research organizations across the globe due to the unavailability of resources and restriction on human mobilities.

Which regions are likely to hold the largest revenue share during the forecast period?

North America and Europe are likely to hold the maximum revenue share during the forecast period.

Which end-user segment accounted for the largest market share in 2020?

Academic and research institutes accounted for the largest market share by end-users.

The global genome sequencing market by revenue is expected to grow at a CAGR of over 9% during the period 2021–2026.

The following factors are likely to contribute to the growth of the genome sequencing market during the forecast period:

Increase in Demand for Single Cell Sequencing
Introduction of Portable Genome Sequencing Devices
The emergence of Nanopore, Third Generation Genome Sequencing Platform

Base Year: 2020

Forecast Year: 2021–2026

The study considers the genome sequencing market's present scenario and its market dynamics for the period 2020−2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

Prominent Vendors

Illumina
- Business Overview
- Product Offerings
- Key Strengths
- Key Strategies
- Key Opportunities
Thermo Fisher Scientific
Oxford Nanopore Technology
Pacific Biosciences
F. Hoffmann-La Roche
BGI

Other Prominent Vendors

PerkinElmer
- Business Overview
- Product Offerings
Siemens Healthineers
Qiagen
Macrogen
Myriad Genetics
Intrexon Bioinformatics
Biomatters
Cytiva
10x Genomics
MGI Tech
New England Biolabs
DNASTAR
Beckman Coulter
VEROGEN
Bio-Rad

Product

Consumables
Sequencers & Software

Application

Oncology
Reproductive Health
Complex Disease Research
Microbial Research
Others

End-user

Academic & Research Institutes
Pharma & Biotech Companies
Consumer Genomic Service Providers
Government & Commercial Laboratories
Others

Geography

North America
- US
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
APAC
- China
- India
- Japan
- South Korea
- Australia
Latin America
- Mexico
- Brazil
- Argentina
Middle East & Africa
- Saudi Arabia
- Turkey
- South Africa
- UAE

List Of Exhibits

Exhibit 1 Segmentation of Global Genome Sequencing Market

Exhibit 2 Market Size Calculation Approach 2020

Exhibit 3 Benefits of Next Generation Sequencing

Exhibit 4 Impact of Increase in the Demand for Single Cell Sequencing

Exhibit 5 Advantages of Sigle Cell Sequencing

Exhibit 6 Impact of Introduction of Portable Genome Sequencing Devices

Exhibit 7 Impact of Emergence of Nanopore, Third Generation Genome Sequencing Platform

Exhibit 8 Impact of Rising Patient Population

Exhibit 9 Global Rare Diseases Statistics Overview

Exhibit 10 Prevalence Rate of Selected Rare Diseases Worldwide as of 2017 (per 100,000 population)

Exhibit 11 Impact of Declining Cost of Genome Sequencing

Exhibit 12 Lower Sequencing Cost Expands Customer and Application Reach

Exhibit 13 Impact of Increasing Genome Sequencing Service Providers

Exhibit 14 Impact of the Covid-19 Pandemic on the Genome Sequencing Market

Exhibit 15 COVID-19 Cases in Key Countries

Exhibit 16 Revenue Comparison of Illumina during COVID-19 Pandemic ($million)

Exhibit 17 Impact of Low Penetration of Genome Sequencing in Developing Countries

Exhibit 18 Impact Ethical & Regulatory Concerns Associated with Genome Sequencing

Exhibit 19 Global Genome Sequencing Market 2020–2026 ($ million)

Exhibit 20 Global Genome Sequencing Market by Product

Exhibit 21 Global Genome Sequencing Market by Application

Exhibit 22 Global Genome Sequencing Market by End-user

Exhibit 23 Global Genome Sequencing Market by Geography

Exhibit 24 Five Forces Analysis 2020

Exhibit 25 Incremental Growth by Product 2020 & 2026

Exhibit 26 Global Genome Sequencing Market by Product

Exhibit 27 Global Genome Sequencing Market by Product: Incremental Growth

Exhibit 28 Global Genome Sequencing Market by Product: Absolute Growth

Exhibit 29 Global Genome Sequencing Market by Consumables: Incremental Growth versus Absolute Growth

Exhibit 30 Global Genome Sequencing Market by Consumables 2020–2026 ($ million)

Exhibit 31 Incremental Growth by Geography 2020 & 2026

Exhibit 32 Global Genome Sequencing Market by Sequencers & Softwares: Incremental Growth versus Absolute Growth

Exhibit 33 Global Genome Sequencing Market by Sequencers & Software 2020–2026 ($ million)

Exhibit 34 Incremental Growth by Geography 2020 & 2026

Exhibit 35 Incremental Growth by Application 2020 & 2026

Exhibit 36 Global Genome Sequencing Market by Application

Exhibit 37 Global Genome Sequencing Market by Application: Incremental Growth

Exhibit 38 Global Genome Sequencing Market by Application: Absolute Growth

Exhibit 39 Global Genome Sequencing Market by Oncology: Incremental Growth versus Absolute Growth

Exhibit 40 Global Genome Sequencing Market by Oncology 2020–2026 ($ million)

Exhibit 41 Incremental Growth by Geography 2020 & 2026

Exhibit 42 Global Genome Sequencing Market by Reproductive Health: Incremental Growth versus Absolute Growth

Exhibit 43 Global Genome Sequencing Market by Reproductive Health 2020–2026 ($ million)

Exhibit 44 Incremental Growth by Geography 2020 & 2026

Exhibit 45 Global Genome Sequencing Market by Complex Disease Research: Incremental Growth versus Absolute Growth

Exhibit 46 Global Genome Sequencing Market by Complex Disease Research 2020–2026 ($ million)

Exhibit 47 Incremental Growth by Geography 2020 & 2026

Exhibit 48 Global Genome Sequencing Market by Microbial Research: Incremental Growth versus Absolute Growth

Exhibit 49 Global Genome Sequencing Market by Microbial Research 2020–2026 ($ million)

Exhibit 50 Incremental Growth by Geography 2020 & 2026

Exhibit 51 Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth

Exhibit 52 Global Genome Sequencing Market by Others 2020–2026 ($ million)

Exhibit 53 Incremental Growth by Geography 2020 & 2026

Exhibit 54 Incremental Growth by End-User 2020 & 2026

Exhibit 55 Global Genome Sequencing Market by End-User

Exhibit 56 Global Genome Sequencing Market by End-User: Incremental Growth

Exhibit 57 Global Genome Sequencing Market by End-User: Absolute Growth

Exhibit 58 Global Genome Sequencing Market by Academic & Research Institutes: Incremental Growth versus Absolute Growth

Exhibit 59 Global Genome Sequencing Market by Academic & Research Institutes 2020–2026 ($ million)

Exhibit 60 Incremental Growth by Geography 2020 & 2026

Exhibit 61 Global Genome Sequencing Market by Pharma & Biotech Companies: Incremental Growth versus Absolute Growth

Exhibit 62 Global Genome Sequencing Market by Pharma & Biotechnology Companies 2020–2026 ($ million)

Exhibit 63 Incremental Growth by Geography 2020 & 2026

Exhibit 64 Global Genome Sequencing Market by Consumer Genomic Service Provider: Incremental Growth versus Absolute Growth

Exhibit 65 Global Genome Sequencing Market by Consumer Genomic Service Providers 2020–2026 ($ million)

Exhibit 66 Incremental Growth by Geography 2020 & 2026

Exhibit 67 Global Genome Sequencing Market by Government & Commercial Labs: Incremental Growth versus Absolute Growth

Exhibit 68 Global Genome Sequencing Market by Government and Commercial Labs 2020–2026 ($ million)

Exhibit 69 Incremental Growth by Geography 2020 & 2026

Exhibit 70 Global Genome Sequencing Market by Others: Incremental Growth versus Absolute Growth

Exhibit 71 Global Genome Sequencing Market by Others 2020–2026 ($ million)

Exhibit 72 Incremental Growth by Geography 2020 & 2026

Exhibit 73 Incremental Growth by Geography 2020 & 2026

Exhibit 74 Global Genome Sequencing Market by Geography

Exhibit 75 Global Genome Sequencing Market by Geography: Incremental Growth

Exhibit 76 Global Genome Sequencing Market by Geography: Absolute Growth

Exhibit 77 Genome Sequencing Market in North America: Key Countries in 2020

Exhibit 78 Genome Sequencing Market in North America: Incremental Growth versus Absolute Growth

Exhibit 79 Genome Sequencing Market in North America 2020–2026 ($ million)

Exhibit 80 Incremental Growth by Product 2020 & 2026

Exhibit 81 Incremental Growth by Application 2020 & 2026

Exhibit 82 Incremental Growth by End-User 2020 & 2026

Exhibit 83 Incremental Growth in North America 2020 & 2026

Exhibit 84 Genome Sequencing Market in US 2020–2026 ($ million)

Exhibit 85 Genome Sequencing Market in Canada 2020–2026 ($ million)

Exhibit 86 Genome Sequencing Market in Europe: Key Countries in 2020

Exhibit 87 Genome Sequencing Market in Europe: Incremental Growth versus Absolute Growth

Exhibit 88 Genome Sequencing Market in Europe 2020–2026 ($ million)

Exhibit 89 Incremental Growth by Product 2020 & 2026

Exhibit 90 Incremental Growth by Application 2020 & 2026

Exhibit 91 Incremental Growth by End-User 2020 & 2026

Exhibit 92 Incremental Growth in Europe 2020 & 2026

Exhibit 93 Genome Sequencing Market in Germany 2020–2026 ($ million)

Exhibit 94 Genome Sequencing Market in France 2020–2026 ($ million)

Exhibit 95 Genome Sequencing Market in UK 2020–2026 ($ million)

Exhibit 96 Genome Sequencing Market in Italy 2020–2026 ($ million)

Exhibit 97 Genome Sequencing Market in Spain 2020–2026 ($ million)

Exhibit 98 Genome Sequencing Market in APAC: Key Countries in 2020

Exhibit 99 Genome Sequencing Market in APAC: Incremental Growth versus Absolute Growth

Exhibit 100 Genome Sequencing Market in APAC 2020–2026 ($ million)

Exhibit 101 Incremental Growth by Product 2020 & 2026

Exhibit 102 Incremental Growth by Application 2020 & 2026

Exhibit 103 Incremental Growth by End-User 2020 & 2026

Exhibit 104 Incremental Growth in APAC 2020 & 2026

Exhibit 105 Genome Sequencing Market in China 2020–2026 ($ million)

Exhibit 106 Genome Sequencing Market in Japan 2020–2026 ($ million)

Exhibit 107 Genome Sequencing Market in Australia 2020–2026 ($ million)

Exhibit 108 Genome Sequencing Market in South Korea 2020–2026 ($ million)

Exhibit 109 Genome Sequencing Market in India 2020–2026 ($ million)

Exhibit 110 Genome Sequencing Market in Latin America: Key Countries in 2020

Exhibit 111 Global Genome Sequencing Market in Latin America: Incremental Growth versus Absolute Growth

Exhibit 112 Genome Sequencing Market in Latin America 2020–2026 ($ million)

Exhibit 113 Incremental Growth by Product 2020 & 2026

Exhibit 114 Incremental Growth by Application 2020 & 2026

Exhibit 115 Incremental Growth by End-User 2020 & 2026

Exhibit 116 Incremental Growth in Latin America 2020 & 2026

Exhibit 117 Genome Sequencing Market in Brazil 2020–2026 ($ million)

Exhibit 118 Genome Sequencing Market in Mexico 2020–2026 ($ million)

Exhibit 119 Genome Sequencing Market in Argentina 2020–2026 ($ million)

Exhibit 120 Genome Sequencing Market in Middle East & Africa: Key Countries in 2020

Exhibit 121 Genome Sequencing Market in Middle East & Africa: Incremental Growth versus Absolute Growth

Exhibit 122 Genome Sequencing Market in Middle East & Africa 2020–2026 ($ million)

Exhibit 123 Incremental Growth by Product 2020 & 2026

Exhibit 124 Incremental Growth by Application 2020 & 2026

Exhibit 125 Incremental Growth by End-User 2020 & 2026

Exhibit 126 Incremental Growth in Middle East & Africa 2020 & 2026

Exhibit 127 Genome Sequencing Market in Turkey 2020–2026 ($ million)

Exhibit 128 Genome Sequencing Market in Saudi Arabia 2020–2026 ($ million)

Exhibit 129 Genome Sequencing Market in UAE 2020–2026 ($ million)

Exhibit 130 Genome Sequencing Market in South Africa 2020–2026 ($ million)

Exhibit 131 Vendor’s Market Shares in the Global Genome Sequencing Market-2020

Exhibit 132 Illumina Revenue 2017−2019 ($ millions)

Exhibit 133 Illumina Research & Development Expenditure 2017−2019 ($ millions)

Exhibit 134 Illumina Consumables & Sequencers Revenue 2017−2019 ($ millions)

Exhibit 135 Thermo Fisher Scientific Revenue 2017−2019 ($ millions)

Exhibit 136 Thermo Fisher Scientific Research & Development Expenditure 2017−2019 ($ millions)

Exhibit 137 Thermo Fisher Scientific: Revenue by Geography (%)

List Of Tables

Table 1 Key Caveats

Table 2 Currency Conversion 2013−2020

Table 3 Comparison of Portable NGS Approaches to Existing Technologies

Table 4 Lower Sequencing Cost Broadens Customer and Application Reach

Table 5 Key Genome Sequencing Service Providers

Table 6 Various Generations of Sequencing Technologies

Table 7 Major Genome Sequencing Research Institutes

Table 8 Global Genome Sequencing Market: Vendors Ranking

Table 9 Illumina: Major Product Offerings

Table 10 Thermo Fisher Scientific: Major Product Offerings

Table 11 Oxford Nanopore Technologies: Major Product Offerings

Table 12 Pacific Biosciences: Major Product Offerings

Table 13 F. Hoffmann-La Roche: Major Product Offerings

Table 14 BGI: Major Product Offerings

Table 15 PerkinElmer: Major Product Offerings

Table 16 Siemens Healthineers: Major Product Offerings

Table 17 Qiagen: Major Product Offerings

Table 18 Macrogen: Major Product Offerings

Table 19 Myriad Genetics: Major Product Offerings

Table 20 Intrexon Bioinformatics: Major Product Offerings

Table 21 BioMatter: Major Product Offerings

Table 22 Cytiva: Major Product Offerings

Table 23 10x Genomics: Major Product Offerings

Table 24 MGI Tech: Major Product Offerings

Table 25 New England Biolabs: Major Product Offerings

Table 26 DNASTAR: Major Product Offerings

Table 27 Beckman Coulter: Major Product Offerings

Table 28 VEROGEN: Major Product Offerings

Table 29 Bio-Rad: Major Product Offerings

Table 30 Global Genome Sequencing Market by Geography 2020−2026 ($ million)

Table 31 Global Genome Sequencing Market by Geography 2020−2026 (%)

Table 32 Global Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 33 Global Genome Sequencing Market by End-User 2020−2026 (%)

Table 34 North America Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 35 North America Genome Sequencing Market by End-User 2020−2026 (%)

Table 36 Europe Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 37 Europe Genome Sequencing Market by End-User 2020−2026 (%)

Table 38 APAC Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 39 APAC Genome Sequencing Market by End-User 2020−2026 (%)

Table 40 Latin America Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 41 Latin America Genome Sequencing Market by End-User 2020−2026 (%)

Table 42 Middle East & Africa Genome Sequencing Market by End-User 2020−2026 ($ million)

Table 43 Middle East & Africa Genome Sequencing Market by End-User 2020−2026 (%)

Table 44 Global Genome Sequencing Market by Application 2020−2026 ($ million)

Table 45 Global Genome Sequencing Market by Application 2020−2026 (%)

Table 46 North America Genome Sequencing Market by Application 2020−2026 ($ million)

Table 47 North America Genome Sequencing Market by Application 2020−2026 (%)

Table 48 Europe Genome Sequencing Market by Application 2020−2026 ($ million)

Table 49 Europe Genome Sequencing Market by Application 2020−2026 (%)

Table 50 APAC Genome Sequencing Market by Application 2020−2026 ($ million)

Table 51 APAC Genome Sequencing Market by Application 2020−2026 (%)

Table 52 Latin America Genome Sequencing Market by Application 2020−2026 ($ million)

Table 53 Latin America Genome Sequencing Market by Application 2020−2026 (%)

Table 54 Middle East & Africa Genome Sequencing Market by Application 2020−2026 ($ million)

Table 55 Middle East & Africa Genome Sequencing Market by Application 2020−2026 (%)

Table 56 Global Genome Sequencing Market by Product 2020−2026 ($ million)

Table 57 Global Genome Sequencing Market by Product 2020−2026 (%)

Table 58 North America Genome Sequencing Market by Product 2020−2026 ($ million)

Table 59 North America Genome Sequencing Market by Product 2020−2026 (%)

Table 60 Europe Genome Sequencing Market by Product 2020−2026 ($ million)

Table 61 Europe Genome Sequencing Market by Product 2020−2026 (%)

Table 62 APAC Genome Sequencing Market by Product 2020−2026 ($ million)

Table 63 APAC Genome Sequencing Market by Product 2020−2026 (%)

Table 64 Latin America Genome Sequencing Market by Product 2020−2026 ($ million)

Table 65 Latin America Genome Sequencing Market by Product 2020−2026 (%)

Table 66 Middle East & Africa Genome Sequencing Market by Product 2020−2026 ($ million)

Table 67 Middle East &Africa Genome Sequencing Market by Product 2020−2026 (%)

1 Research Methodology

2 Research Objectives

3 Research Process

4 Scope & Coverage

4.1 Market Definition

4.1.1 Inclusions

4.1.2 Exclusions

4.2 Base Year

4.3 Scope of The Study

4.4 Market Segments

4.4.1 Market Segmentation by Product

4.4.2 Market Segmentation by Application

4.4.3 Market Segmentation by End-user

4.4.4 Market Segmentation by Geography

5 Report Assumptions & Caveats

5.1 Key Caveats

5.2 Currency Conversion

5.3 Market Derivation

6 Market at a Glance

7 Introduction

7.1 Overview

8 Market Opportunities & Trends

8.1 Increase In The Demand For Single-Cell Sequencing

8.2 Introduction Of Portable Genome Sequencing Devices

8.3 Emergence Of Nanopore, Third Generation Genome Sequencing Platform

9 Market Growth Enablers

9.1 Rising Patient Population

9.2 Declining Cost of Genome Sequencing

9.3 Increasing Genome Sequencing Service Providers

10 Market Restraints

10.1 Influence Of The COVID-19 Pandemic On The Genome Sequencing Market

10.2 Low Penetration Of Genome Sequencing In Developing Countries

10.3 Ethical & Regulatory Concerns Associated With Genome Sequencing

11 Market Landscape

11.1 Market Overview

11.2 Market Size & Forecast

11.3 Five Forces Analysis

11.3.1 Threat of New Entrants

11.3.2 Bargaining Power of Suppliers

11.3.3 Bargaining Power of Buyers

11.3.4 Threat of Substitutes

11.3.5 Competitive Rivalry

12 Product

12.1 Market Snapshot & Growth Engine

12.2 Market Overview

12.3 Consumables

12.3.1 Market Overview

12.3.2 Market Size & Forecast

12.3.3 Consumables: Geography Segmentation

12.4 Sequencers & Software

12.4.1 Market Overview

12.4.2 Market Size & Forecast

12.4.3 Sequencers & Software: Geography Segmentation

13 Application

13.1 Market Snapshot & Growth Engine

13.2 Market Overview

13.3 Oncology

13.3.1 Market Overview

13.3.2 Market Size & Forecast

13.3.3 Oncology: Geography Segmentation

13.4 Reproductive Health

13.4.1 Market Overview

13.4.2 Market Size & Forecast

13.4.3 Reproductive Health: Geography Segmentation

13.5 Complex Disease Research

13.5.1 Market Overview

13.5.2 Market Size & Forecast

13.5.3 Complex Disease Research: Geography Segmentation

13.6 Microbial Research

13.6.1 Market Overview

13.6.2 Market Size & Forecast

13.6.3 Microbial Research: Geography Segmentation

13.7 Others

13.7.1 Market Overview

13.7.2 Market Size & Forecast

13.7.3 Others: Geography Segmentation

14 End-User

14.1 Market Snapshot & Growth Engine

14.2 Market Overview

14.3 Academic & Research Institutes

14.3.1 Market Overview

14.3.2 Market Size & Forecast

14.3.3 Academic & Research Institute : Geography Segmentation

14.4 Pharma & Biotechnology Companies

14.4.1 Market Overview

14.4.2 Market Size & Forecast

14.4.3 Pharma & Biotech Companies: Geography Segmentation

14.5 Consumer Genomic Service Providers

14.5.1 Market Overview

14.5.2 Market Size & Forecast

14.5.3 Consumer Genomic Service Providers: Geography Segmentation

14.6 Government and Commercial Labs

14.6.1 Market Overview

14.6.2 Market Size & Forecast

14.6.3 Government & Commercial Labs: Geography Segmentation

14.7 Others

14.7.1 Market Overview

14.7.2 Market Size & Forecast

14.7.3 Others: Geography Segmentation

15 Geography

15.1 Market Snapshot & Growth Engine

15.2 Geographic Overview

16 North America

16.1 Market Overview

16.2 Market Size & Forecast

16.3 North America: Product

16.4 North America: Application

16.5 North America: End-User

16.6 Key Countries

16.6.1 US: Market Size & Forecast

16.6.2 Canada: Market Size & Forecast

17 Europe

17.1 Market Overview

17.2 Market Size & Forecast

17.3 Europe: Product

17.4 Europe: Application

17.5 Europe: End-User

17.6 Key Countries

17.6.1 Germany: Market Size & Forecast

17.6.2 France: Market Size & Forecast

17.6.3 UK: Market Size & Forecast

17.6.4 Italy: Market Size & Forecast

17.6.5 Spain: Market Size & Forecast

18 APAC

18.1 Market Overview

18.2 Market Size & Forecast

18.3 APAC: Product

18.4 APAC: Application

18.5 APAC: End-User

18.6 Key Countries

18.6.1 China: Market Size & Forecast

18.6.2 Japan: Market Size & Forecast

18.6.3 Australia: Market Size & Forecast

18.6.4 South Korea: Market Size & Forecast

18.6.5 India: Market Size & Forecast

19 Latin America

19.1 Market Overview

19.2 Market Size & Forecast

19.3 Latin America: Product

19.4 Latin America: Application

19.5 Latin America: End-User

19.6 Key Countries

19.6.1 Brazil: Market Size & Forecast

19.6.2 Mexico: Market Size & Forecast

19.6.3 Argentina: Market Size & Forecast

20 Middle East and Africa

20.1 Market Overview

20.2 Market Size & Forecast

20.3 Middle East & Africa: Product

20.4 Middle East & Africa: Application

20.5 Middle East & Africa: End-User

20.6 Key Countries

20.6.1 Turkey: Market Size & Forecast

20.6.2 Saudi Arabia: Market Size & Forecast

20.6.3 UAE: Market Size & Forecast

20.6.4 South Africa: Market Size & Forecast

21 Competitive Landscape

21.1 Competition Overview

21.2 Market Share Analysis

21.2.1 Illumina

21.2.2 Thermo Fisher Scientific

21.2.3 Oxford Nanopore Technology

21.2.4 Pacific Biosciences

21.2.5 F. Hoffmann-La Roche

21.2.6 BGI

22 Key Company Profiles

22.1 Illumina

22.1.1 Business Overview

22.1.2 Product Offerings

22.1.3 Key Strategies

22.1.4 Key Strengths

22.1.5 Key Opportunities

22.2 Thermo Fisher Scientific

22.2.1 Business Overview

22.2.2 Product Offerings

22.2.3 Key Strategies

22.2.4 Key Strengths

22.2.5 Key Opportunities

22.3 Oxford NanoPore Technologies

22.3.1 Business Overview

22.3.2 Product Offerings

22.3.3 Key Strategy

22.3.4 Key Strengths

22.3.5 Key Opportunities

22.4 Pacific Biosciences

22.4.1 Business Overview

22.4.2 Product Offerings

22.4.3 Key Strategies

22.4.4 Key Strengths

22.4.5 Key Opportunities

22.5 F.Hoffmann-La Roche

22.5.1 Business Overview

22.5.2 Product Offerings

22.5.3 Key Strategies

22.5.4 Key Strengths

22.5.5 Key Opportunities

22.6 BGI

22.6.1 Business Overview

22.6.2 Product Offerings

22.6.3 Key Strategies

22.6.4 Key Strengths

22.6.5 Key Opportunities

23 Other Prominent Vendors

23.1 PerkinElmer

23.1.1 Business Overview

23.1.2 Product Offerings

23.2 Siemens Healthineers

23.2.1 Business Overview

23.2.2 Product Offerings

23.3 Qiagen

23.3.1 Business Overview

23.3.2 Product Offerings

23.4 Macrogen

23.4.1 Business Overview

23.4.2 Product Offerings

23.5 myriad Genetics

23.5.1 Business Overview

23.5.2 Product Offerings

23.6 Intrexon Bioinformatics

23.6.1 Business Overview

23.6.2 Product Offerings

23.7 Biomatter

23.7.1 Business Overview

23.7.2 Product Offerings

23.8 Cytiva

23.8.1 Business Overview

23.8.2 Product Offerings

23.9 10x Genomics

23.9.1 Business Overview

23.9.2 Product Offerings

23.10 MGI TECH

23.10.1 Business Overview

23.10.2 Product Offerings

23.11 New England Biolabs

23.11.1 Business Overview

23.11.2 Product Offerings

23.12 DNASTAR

23.12.1 Business Overview

23.12.2 Product Offerings

23.13 Beckman Coulter

23.13.1 Business Overview

23.13.2 Product Offerings

23.14 Verogen

23.14.1 Business Overview

23.14.2 Product Offerings

23.15 Bio-Rad

23.15.1 Business Overview

23.15.2 Product Offerings

24 Report Summary

24.1 Key Takeaways

24.2 Strategic Recommendations

25 Quantitative Summary

25.1 Market By Geography

25.2 Market By End-User

25.2.1 North America: End-User

25.2.2 Europe: End-User

25.2.3 APAC: End-User

25.2.4 Latin America: End-User

25.2.5 Middle East & Africa: End-User

25.3 Market By Application

25.3.1 North America: Application

25.3.2 Europe: Application

25.3.3 APAC: Application

25.3.4 Latin America: Application

25.3.5 Middle East & Africa: Application

25.4 Market By Product

25.4.1 North America: Product

25.4.2 Europe: Product

25.4.3 APAC: Product

25.4.4 Latin America: Product

25.4.5 Middle East & Africa: Product

26 Appendix

26.1 Abbreviations

Select a license type that suits your business needs

Single User Licence

$3750.00

Report accessible by one user only
Free 10% or 3 days of customization
Free post-sale service assistance
Continuous support through email

5 User Licence

$4250.00

Report accessible by 5 users within the organization
Free 15% or 4.5 days of customization
Continuous support through email and telephone
Free analyst hour
Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Corporate Licence

$5250.00

Free Datasheet worth $1500
Report accessible by the entire organization
Free 20% or 6 days of customization
Free post-sale service assistance
Continuous support through email and telephone
Direct access to lead analysts
Free analyst hour
Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge

Datasheet Licence

$1500.00

Report accessible by 1 user only
Free 15% or 32 hours of customization
Free post-sale service assistance
Direct access to lead analysts